| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | CN1076969C Preparation for substitution therapy containing at least one progestogen and at least one extrogen |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/26/2001 | CN1328463A Use of 17-ketosteroid compounds, as well as derivatives, metabolites and precursors for treatment of hapatitis C type virus and other togavirus infections |
| 12/26/2001 | CN1076607C Process for preparing pharmaceutical composition containing novel steroid esters |
| 12/26/2001 | CN1076606C Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 12/20/2001 | WO2001096293A1 Vitamin d derivatives |
| 12/19/2001 | EP1163257A1 Method for producing 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 12/19/2001 | EP1163256A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 12/19/2001 | EP1123100A4 Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof |
| 12/18/2001 | US6331535 Retinyl carbonate derivatives, preparation process and uses |
| 12/13/2001 | WO2001021157A3 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 12/11/2001 | US6329354 Administering bone active phosphonate, administering estrogen hormone |
| 12/06/2001 | US20010049146 Stabilization of biological fluids by addition of sterol esters |
| 12/05/2001 | EP1159965A2 Method of preventing or inhibiting fertilization |
| 12/05/2001 | CN1324802A Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 11/28/2001 | EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs |
| 11/28/2001 | EP0678027B1 Anti-atherosclerotic agents |
| 11/28/2001 | CN1323800A Pseudo gensenoside-Pgq and its semi-synthesis and medicinal use |
| 11/27/2001 | US6322987 Carbamate-derivatized nucleosides and oligonucleosides |
| 11/22/2001 | US20010044432 Administering estradiol derivative |
| 11/15/2001 | WO2001060375A8 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 11/14/2001 | EP0686613B1 Ozonide reducing agent |
| 11/14/2001 | CN1322210A High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 11/14/2001 | CN1322130A Inhibitors of type 3 3a -hydrosteroid dehydrogenase |
| 11/13/2001 | US6316432 Antigestagenically active steroids with a flourinated 17 α-alkyl chain |
| 11/08/2001 | WO2001084144A1 Method for in vitro screening of drug candidates useful for the prevention of bone resorption |
| 11/08/2001 | US20010039269 Treatment of prostate disorders such as prostatic cancer |
| 11/07/2001 | EP0712497B1 Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 11/06/2001 | US6313108 Treating androgen insufficiency |
| 10/31/2001 | EP1149838A1 Estriol substantially free of 16alpha, 17alpha-estra-1,3,5(10)-triene-3,16,17-triol |
| 10/24/2001 | EP1148061A2 Process for preparation of 9, 11- epoxy steroids and intermediates useful therein |
| 10/23/2001 | US6306595 Design of drugs involving receptor-ligand-DNA interactions |
| 10/18/2001 | WO2001077139A1 8ss-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS |
| 10/18/2001 | WO2001077138A1 8β-SUBSTITUTED-11β-PENTYL- AND 11β-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
| 10/18/2001 | DE10019167A1 New 8 beta-substituted 11 beta-(pentyl or hexyl)-estra-1,3,5(10)-triene derivatives, are ovary-selective estrogen receptor ligands useful e.g. as female or male contraceptives or for treating ovarian carcinoma |
| 10/17/2001 | EP1144431A2 16-hydroxyestratrienes as selective estrogens |
| 10/17/2001 | EP1143978A2 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 10/17/2001 | EP1143947A2 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 10/17/2001 | EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 10/11/2001 | WO2001074839A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 10/11/2001 | WO2001074366A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/11/2001 | DE10011883A1 New non-solvated crystalline form of fluorinated estratriene-diol derivative, useful as antiestrogen e.g. for treating breast or endometrial cancer, chemotherapy-induced alopecia, endometriosis or anovulatory infertility |
| 10/11/2001 | CA2403608A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 10/10/2001 | CN1072678C Trifluoro-methyl steroid, preparation and its application |
| 09/26/2001 | EP1135138A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 09/26/2001 | CN1071573C Anti-atteroscherotic use of 17 alpha-dihydroeoquilin |
| 09/20/2001 | WO2001068669A1 6-oxygenated steroidal estrogens with aromatic a and b rings |
| 09/19/2001 | EP1133287A2 Use of 17-ketosteroids for the treatment of hepatitis c virus and other togaviruses |
| 09/19/2001 | EP0728140B1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 09/19/2001 | CN1313862A Novel 17-halogenated 19-Nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 09/13/2001 | WO2001066561A1 Preventive or therapeutic drugs for eye diseases |
| 09/13/2001 | WO2001005805A3 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/12/2001 | EP1131336A1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 09/11/2001 | US6288051 Estrogen-dependent breast cancer treatment |
| 09/07/2001 | WO2001064193A2 Exemestane for first-line treatment of breast cancer |
| 09/07/2001 | WO2001014406A8 Antiandrogen agents |
| 09/07/2001 | WO2000047603A9 16-hydroxyestratrienes as selective estrogens |
| 09/07/2001 | CA2401041A1 Breast cancer hormonal therapy |
| 09/05/2001 | CN1311682A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol |
| 09/05/2001 | CN1070499C Process for prepn. of 6 alpha, 9 alpha-difluorinated steroids and intermediates thereof |
| 09/04/2001 | US6285537 Stress-follower circuit configuration |
| 09/04/2001 | US6284750 Drug, cosmetics steroid |
| 08/30/2001 | WO2001010430A3 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/23/2001 | WO2001060836A1 Process for the preparation of steroid derivatives |
| 08/23/2001 | WO2001060376A1 Male contraceptive formulation comprising norethisterone |
| 08/23/2001 | WO2001060375A2 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 08/23/2001 | CA2398706A1 Cytoprotective steroids (ii) |
| 08/23/2001 | CA2398063A1 Male contraceptive formulation comprising norethisterone |
| 08/22/2001 | EP1124545A2 Use of estrogenic compounds as anti-fungal agents |
| 08/16/2001 | WO2001058919A2 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 08/16/2001 | EP1123100A1 Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof |
| 08/14/2001 | US6274746 Process for allylic oxidation using metal hypochlorite and alkyl hydroperoxide |
| 08/09/2001 | WO2001056577A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
| 08/09/2001 | WO2000066095A3 Use of estrone derivatives as antitumour agents |
| 08/09/2001 | CA2397790A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
| 08/08/2001 | EP1121941A1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 08/08/2001 | EP1121375A1 High purity composition comprising (7alpha,17alpha)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one |
| 08/07/2001 | US6271220 Anticancer, antiarthritic agents |
| 08/02/2001 | WO2000047603A3 16-hydroxyestratrienes as selective estrogens |
| 08/02/2001 | EP1144431A3 16-hydroxyestratrienes as selective estrogens |
| 07/26/2001 | WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 07/26/2001 | US20010009680 Such as various cancers, by administering low molecular weight compounds of following properties: extractable from bile of an animal, stimulates monocytes and macrophages, modulates tumor necrosis factor production, not endotoxin |
| 07/25/2001 | CN1305488A Testosterone derivative |
| 07/19/2001 | WO2001051055A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/19/2001 | WO2001051023A1 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin |
| 07/19/2001 | WO2001051022A1 Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators |
| 07/19/2001 | DE19961219A1 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 11beta-Phenylestratrien derivatives with fluoroalkyl groups in the aromatic side chain, their preparation and pharmaceutical compositions containing them |
| 07/19/2001 | CA2396098A1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/17/2001 | US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/17/2001 | CA2130515C New 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethylestradiene derivatives, methods for their production and pharmaceuticals containing these substances |
| 07/12/2001 | US20010007859 Anticancer agents; central nervous system disorders; skin disorders; Alzheimer's disease |
| 07/11/2001 | CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/10/2001 | US6258803 11-ethyl-17-hydroxy-19-norpregn-4-en-20-yn-3-one for menopause treatment |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/04/2001 | EP0666746B1 $g(D)5-ANDROSTENES USEFUL FOR PROMOTING WEIGHT MAINTENANCE OR WEIGHT LOSS AND TREATMENT PROCESS |
| 07/04/2001 | CN1301704A Method for extracting hytosterol from vegitable oil asphalt or tall oil asphalt |